Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?
Athanasios Fountas, Leonidas Nikolaos Diamantopoulos, Agathocles Tsatsoulis
Trends in Endocrinology and Metabolism (2015) Vol. 26, Iss. 11, pp. 643-656
Closed Access | Times Cited: 88

Showing 26-50 of 88 citing articles:

<p>Galangin Inhibits LPS-Induced MMP-9 Expression via Suppressing Protein Kinase-Dependent AP-1 and FoxO1 Activation in Rat Brain Astrocytes</p>
Chien-Chung Yang, Li‐Der Hsiao, Chuen‐Mao Yang
Journal of Inflammation Research (2020) Vol. Volume 13, pp. 945-960
Open Access | Times Cited: 24
Apoptosis in Type 2 Diabetes: Can It Be Prevented? Hippo Pathway Prospects
Agnieszka Kilanowska, Agnieszka Ziółkowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 636-636
Open Access | Times Cited: 15
The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice
Yue Gu, Elisa Avolio, Valeria Vincenza Alvino, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors
P. Buffier, Benjamin Bouillet, Sarra Smati, et al.
Annales d Endocrinologie (2018) Vol. 79, Iss. 5, pp. 574-582
Closed Access | Times Cited: 26
One reporter for in-cell activity profiling of majority of protein kinase oncogenes
Iva Gudernová, Silvie Foldynová-Trantírková, Barbora El Ghannamova, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 25
Phosphoprotein network analysis of white adipose tissues unveils deregulated pathways in response to high-fat diet
Asfa Alli‐Shaik, Beiying Qiu, Sheena Wee, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 24
GALNT2 as a novel modulator of adipogenesis and adipocyte insulin signaling
Antonella Marucci, Alessandra Antonucci, Concetta De Bonis, et al.
International Journal of Obesity (2019) Vol. 43, Iss. 12, pp. 2448-2457
Closed Access | Times Cited: 23
Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases
Seonwook Kim, Venkateswaran Subramanian, Ahmed Abdel‐Latif, et al.
Metabolic Syndrome and Related Disorders (2020) Vol. 18, Iss. 4, pp. 186-196
Open Access | Times Cited: 23
Antidiabetic Effects of the Senolytic Agent Dasatinib
Omid Salaami, Chia‐Ling Kuo, Matthew T. Drake, et al.
Mayo Clinic Proceedings (2021) Vol. 96, Iss. 12, pp. 3021-3029
Open Access | Times Cited: 19
Interrogating Kinase–Substrate Relationships with Proximity Labeling and Phosphorylation Enrichment
Tian Zhang, Anne Fassl, Laura Pontano Vaites, et al.
Journal of Proteome Research (2022) Vol. 21, Iss. 2, pp. 494-506
Open Access | Times Cited: 13
Inhibition of epidermal growth factor receptor attenuates LPS-induced inflammation and acute lung injury in rats
Xiaoou Shan, Yali Zhang, Hongjin Chen, et al.
Oncotarget (2017) Vol. 8, Iss. 16, pp. 26648-26661
Open Access | Times Cited: 24
Inherent formulation issues of kinase inhibitors
Maikel Herbrink, Jan H.M. Schellens, Jos H. Beijnen, et al.
Journal of Controlled Release (2016) Vol. 239, pp. 118-127
Open Access | Times Cited: 21
Circulating HER2/ErbB2 Levels Are Associated With Increased Incidence of Diabetes: A Population-Based Cohort Study
Iram Faqir Muhammad, Yan Borné, Xue Bao, et al.
Diabetes Care (2019) Vol. 42, Iss. 8, pp. 1582-1588
Closed Access | Times Cited: 21
miR‐181a/b‐5p regulates human umbilical vein endothelial cell angiogenesis by targeting PDGFRA
Tingting Sun, Linan Yin, Hongyu Kuang
Cell Biochemistry and Function (2019) Vol. 38, Iss. 2, pp. 222-230
Closed Access | Times Cited: 20
RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice
Brittany M. Duggan, Joseph F. Cavallari, Kevin P. Foley, et al.
Endocrinology (2020) Vol. 161, Iss. 8
Open Access | Times Cited: 19
Hyperglycemia activates FGFR1 via TLR4/c-Src pathway to induce inflammatory cardiomyopathy in diabetes
Xiong Chen, Jinfu Qian, Shiqi Liang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 4, pp. 1693-1710
Open Access | Times Cited: 2
Kanglexin counters vascular smooth muscle cell dedifferentiation and associated arteriosclerosis through inhibiting PDGFR
Shuang Yang, Yixiu Zhao, Shifeng Cao, et al.
Phytomedicine (2024) Vol. 130, pp. 155704-155704
Closed Access | Times Cited: 2
Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor
Miguel Ángel Gómez-Sámano, Jorge Baquerizo‐Burgos, Marı́a Florencia Coronel, et al.
BMC Endocrine Disorders (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 20
Innovative Computer-Aided Methods for the Discovery of New Kinase Ligands
Areej Abuhammad, Mutasem O. Taha
Future Medicinal Chemistry (2016) Vol. 8, Iss. 5, pp. 509-526
Closed Access | Times Cited: 19
Supramolecular protection from the enzymatic tyrosine phosphorylation in a polypeptide
Enrico Faggi, Yolanda Pérez, Santiago V. Luis, et al.
Chemical Communications (2016) Vol. 52, Iss. 52, pp. 8142-8145
Open Access | Times Cited: 19
A Novel Rhynchophylline Analog, Y396, Inhibits Endothelial Dysfunction Induced by Oxidative Stress in Diabetes Through Epidermal Growth Factor Receptor
Zhijun Wang, Lingling Chang, Jian Wu, et al.
Antioxidants and Redox Signaling (2020) Vol. 32, Iss. 11, pp. 743-765
Closed Access | Times Cited: 18
Modulatory role of imatinib mesylate on pancreatic β-cells' secretory functions in an STZ rat model of diabetes mellitus
Mahmoud M. Samaha, Eman Said, Hatem A. Salem
Chemico-Biological Interactions (2020) Vol. 328, pp. 109197-109197
Closed Access | Times Cited: 15
β-Cell Receptor Tyrosine Kinases in Controlling Insulin Secretion and Exocytotic Machinery: c-Kit and Insulin Receptor
Amanda Oakie, Rennian Wang
Endocrinology (2018) Vol. 159, Iss. 11, pp. 3813-3821
Open Access | Times Cited: 16
Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
Amin Ardestani, Matthew S. Tremblay, Weijun Shen, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 14
Co-delivery of siAlox15 and sunitinib for reversing the new-onset of type 1 diabetes in non-obese diabetic mice
Yang Peng, Di Wen, Feng Lin, et al.
Journal of Controlled Release (2018) Vol. 292, pp. 1-12
Closed Access | Times Cited: 14

Scroll to top